Agilent Technologies said second-quarter revenue rose to $1.83 billion, up 10.0% from a year earlier and 6.3% on a core basis.
Net income climbed to $339 million from $215 million in the prior-year quarter, while earnings per share increased to $1.20 from $0.75. Non-GAAP net income rose to $423 million from $373 million, and non-GAAP EPS increased to $1.49 from $1.31.
Operating margin improved as well. GAAP operating margin was 21.7%, while non-GAAP operating margin was 26.4%, up 130 basis points from a year ago and 180 basis points from the prior quarter.
By business unit, life sciences and diagnostics markets revenue increased 12% to $732 million, with 9% core growth and a 22.0% operating margin. Agilent CrossLab revenue rose 6% to $759 million, with 2% core growth and a 32.0% operating margin. Applied markets revenue increased 14% to $344 million, with 11% core growth and a 23.3% operating margin.
For fiscal 2026, Agilent raised its revenue outlook to $7.39 billion to $7.49 billion, implying reported growth of 6.3% to 7.8% and core growth of 4.5% to 6.0%. The midpoint of that range reflects a 30-basis-point increase in revenue growth guidance. The company also now expects non-GAAP operating margin expansion of 85 basis points at the midpoint, 10 basis points better than before, and non-GAAP EPS of $6.00 to $6.10, up 8 cents at the midpoint.
For the third quarter, Agilent forecast revenue of $1.83 billion to $1.85 billion, up 5.0% to 6.5% reported and 4.4% to 5.9% core, with non-GAAP EPS expected at $1.48 to $1.50. Following these announcements, the company's shares moved 0.4%, and are now trading at a price of $115.535. For the full picture, make sure to review 's 8-K report.
